ePrints

Phase I study of two dosing schedules of the investigational oral pan-RAF kinase inhibitor MLN2480 in patients (pts) with advanced solid tumors or melanoma

Lookup NU author(s): Professor Ruth Plummer

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Rasco DW, Middleton MR, Gonzalez R, Corrie P, Pavlick A, Lorigan P, Plummer R, Gore M, Herbert C, Agarwala SS, Logan TF, Khleif SN, Papadopoulos KP, Rangachari L, Suri A, Xu Q, Kneissl M, Bozon V, Olszanski AJ

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: European Cancer Congress 2015

Year of Conference: 2015

Pages: S53-S54

Print publication date: 01/09/2015

Online publication date: 29/09/2015

Acceptance date: 01/01/1900

Publisher: Elsevier

URL: http://dx.doi.org/10.1016/S0959-8049(15)30005-8

DOI: 10.1016/S0959-8049(15)30005-8

Series Title: European Journal of Cancer

Share